Testing effectiveness (Phase 2)Active Not RecruitingNCT03096093What this trial is testingInvestigation of a Therapeutic Vaccine (ACIT-1) in CancerWho this might be right forCancerNeoplasms Cancer Vaccines Limited 34
Not applicableNo Longer AvailableNCT01980732What this trial is testing68Ga DOTA-TATE PET/CT in Somatostatin Receptor Positive TumorsWho this might be right forCarcinoid TumorsIslet Cell (Pancreatic NET)Other Neuroendocrine Tumors Andrei Iagaru
Testing effectiveness (Phase 2)Active Not RecruitingNCT04396821What this trial is testingA Trial to Evaluate Safety and Tolerability of TST001 in Advanced or Metastatic Solid TumorsWho this might be right forAdvanced CancerGastric CancerGastroesophageal-junction Cancer+1 more Transcenta Therapeutics (Hangzhou) Co., Ltd. 150
Early research (Phase 1)Ended earlyNCT02110563What this trial is testingPhase I, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Solid Tumors, Multiple Myeloma, or LymphomaWho this might be right forSolid TumorsMultiple MyelomaNon-Hodgkins Lymphoma+3 more Dicerna Pharmaceuticals, Inc., a Novo Nordisk company 50
Testing effectiveness (Phase 2)Study completedNCT05864144What this trial is testingSNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid TumorsWho this might be right forSolid Tumor, AdultAdvanced Solid TumorHead and Neck Cancer+19 more Sensei Biotherapeutics, Inc. 98
Early research (Phase 1)Study completedNCT00844064What this trial is testingSafety and Tolerability of AP 12009, Administered I.V. in Patients With Advanced Tumors Known to Overproduce TGF-beta-2Who this might be right forPancreatic NeoplasmsMelanomaColorectal Neoplasms Isarna Therapeutics GmbH 62
Testing effectiveness (Phase 2)Active Not RecruitingNCT05651022What this trial is testingStudy of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid TumorsWho this might be right forSolid Tumor, AdultHCC - Hepatocellular CarcinomaCRC (Colorectal Cancer)+5 more Indaptus Therapeutics, Inc 120
Not applicableLooking for participantsNCT07034339What this trial is testingConstruction and Clinical Application of the Immune Map of Pancreatic Cancer EvolutionWho this might be right forImmune Evasion, TumorPancreas Cancer First Affiliated Hospital of Zhejiang University 1,500
Not applicableWithdrawnNCT03041571What this trial is testingImpact of Early Implementation of Narrative Medicine Techniques on Patient Centered Attitudes of Medical StudentsWho this might be right forNarrative MedicineChronic DiseaseTerminal Illness+6 more University of Florida
Not applicableEnded earlyNCT03244683What this trial is testingThe Efficacy of ONS to Reduce Postoperative Complications Associated With Pancreatic SurgeryWho this might be right forPancreatic CancerChronic Pancreatitis Ohio State University 8
Not applicableUnknownNCT05201729What this trial is testingInfluence Factors of PD-1 Therapeutic Efficacy in Advanced Pancreatic CancerWho this might be right forPancreatic Ductal Adenocarcinoma, PDAC Ruijin Hospital 30
Testing effectiveness (Phase 2)Study completedNCT05795595What this trial is testingA Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid TumorsWho this might be right forClear Cell Renal Cell CarcinomaCervical CarcinomaEsophageal Carcinoma+2 more CRISPR Therapeutics AG 19
Not applicableStudy completedNCT05078775What this trial is testingMedical Food for the Dietary Management of Advanced/Metastatic Pancreatic CancerWho this might be right forMetastatic Pancreatic AdenocarcinomaLocally Advanced Unresectable Pancreatic Adenocarcinoma Faeth Therapeutics 39
Early research (Phase 1)Looking for participantsNCT07106827What this trial is testingGV20-0251 in Advanced or Refractory Solid TumorsWho this might be right forHCC - Hepatocellular CarcinomaCholangiocarcinomaMelanoma+5 more West China Hospital 10
Testing effectiveness (Phase 2)Study completedNCT01417000What this trial is testingSafety and Efficacy of Combination Listeria/GVAX Immunotherapy in Pancreatic CancerWho this might be right forMetastatic Pancreatic Cancer Aduro Biotech, Inc. 93
Not applicableStudy completedNCT05102500What this trial is testingSecond Opinions in OncologyWho this might be right forBreast CancerPancreatic CancerColorectal Cancer University of Colorado, Denver 236
Early research (Phase 1)Study completedNCT01437007What this trial is testingTKM 080301 for Primary or Secondary Liver CancerWho this might be right forColorectal Cancer With Hepatic MetastasesPancreas Cancer With Hepatic MetastaseGastric Cancer With Hepatic Metastase+2 more National Cancer Institute (NCI) 1
Testing effectiveness (Phase 2)Study completedNCT02767557What this trial is testingStudy of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab in Pancreatic Cancer PatientsWho this might be right forUnresectable Pancreatic Carcinoma Herlev Hospital 147
Testing effectiveness (Phase 2)Ended earlyNCT00326911What this trial is testingCetuximab and Bevacizumab With or Without Gemcitabine to Treat Metastatic Pancreatic CancerWho this might be right forMetastatic Pancreatic Cancer Eli Lilly and Company 61
Large-scale testing (Phase 3)UnknownNCT05178628What this trial is testingThe Impact of Thromboprophylaxis on Progression Free Survival of Patients With Advanced Pancreatic CancerWho this might be right forPancreatic CancerThromboembolism Michalis Karamouzis 450